Related Experiment Video
Updated: May 2, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
An analysis of government immunization program expenditures in lower and lower middle income countries 2006-12
Alice Abou Nader1, Ciro de Quadros2, Claudio Politi2
1Sabin Vaccine Institute, 2000 Pennsylvania Ave. Suite 7100, NW, Washington, DC 20006, USA World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland alice.nader@sabin.org.
Insights
As national economies grow, lower and lower-middle-income countries significantly increase spending on routine immunization programs. Economic growth can enable countries to fully finance child immunization without impacting other essential services.
Area of Science:
- Global Health
- Health Economics
- Public Health Policy
Background:
- The cost of childhood immunization is rising, projected to exceed $60 per infant by 2015.
- Spending on routine immunization in lower and lower-middle-income countries increased by 67% from 2006 to 2012, from $12 to $20 per surviving infant.
Purpose of the Study:
- To test the hypothesis that economic growth in lower and lower-middle-income countries leads to increased spending on routine immunization programs.
- To quantify the relationship between national income growth and immunization expenditures.
Main Methods:
- A panel data regression analysis was employed using annual government expenditure data from 2006-2012.
- Expenditures were regressed against lagged per capita Gross National Income (GNI), controlling for mortality, program performance, corruption, region, and data reporting accuracy.
Main Results:
- Immunization expenditures were found to increase significantly with GNI growth.
- For every $100 increase in GNI, countries spent approximately $6.32 more on immunization between 2006 and 2012.
Conclusions:
- Projected GNI growth suggests that countries could reach $60 per infant immunization expenditure by 2020.
- With political will, increased national income can enable full financing of routine immunization programs without diverting funds from other sectors.
Abstract:
Financing is becoming increasingly important as the cost of immunizing the world's children continues to rise. By 2015, that cost will likely exceed US$60 per infant as new vaccines are introduced into national immunization programs. In 2006, 51 lower and lower middle income countries reported spending a mean US$12 per surviving infant on routine immunization. By 2012, the figure had risen to $20, a 67% increase. This study tests the hypothesis that lower and lower middle income countries will spend more on their routine immunization programs as their economies grow. A panel data regression approach is used. Expenditures reported by governments annually (2006-12) through the World Health Organization/UNICEF Joint Reporting Form are regressed on lagged annual per capita gross national income (GNI), controlling for prevailing mortality levels, immunization program performance, corruption control efforts, geographical region and correct reporting. Results show the expenditures increased with GNI. Expressed as an elasticity, the countries spent approximately $6.32 on immunization for every $100 in GNI increase from 2006 to 2012. Projecting forward and assuming continued annual GNI growth rates of 10.65%, countries could be spending $60 per infant by 2020 if national investment functions increase 4-fold. Given the political will, this result implies countries could fully finance their routine immunization programs without cutting funding for other programs.
Related Concept Videos
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Vaccinations
Infectious Diseases and Their Occurrence
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

